CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 98 enrolled
Drug / intervention
Pancreaticoduodenectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02517268
NCT02517268N/ACompleted

A Prospective Randomized Controlled Trial Evaluating an Accelerated 5 Day Pathway for Discharge Following Pancreaticoduodenectomy (PD): Whipple Accelerated Recovery Pathway (WARP Trial)

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University·interventional·Posted Aug 6, 2015·Updated Apr 30, 2025

In Brief

A clinical study evaluating Pancreaticoduodenectomy for Pancreatic Carcinoma. Completed, enrolled 98 participants across 1 site.

Detailed Summary

This randomized clinical trial studies accelerated recovery pathway for discharge after surgery in patients with pancreatic cancer. A standardized accelerated recovery pathway may improve outcomes after surgery following complex abdominal operations resulting in a shorter length of stay in patients with pancreatic cancer. It may also help patients to mobilize more quickly and return to the home setting, decrease hospital-acquired infectious complications, and increase potential cost savings. It is not yet known whether an accelerated recovery pathway is better than a standard recovery pathway for discharge following surgery in patients with pancreatic cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 6, 2015
Enrollment StartJun 24, 2015
Primary CompletionJan 28, 2018
Study CompletionMar 28, 2019
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 10.9 years ago

Interventions

Pancreaticoduodenectomyprocedure